MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 93 filers reported holding MAGENTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $930,000 | -34.6% | 320,698 | 0.0% | 0.03% | -27.5% |
Q4 2021 | $1,421,000 | -39.1% | 320,698 | 0.0% | 0.04% | -39.4% |
Q3 2021 | $2,335,000 | -25.5% | 320,698 | 0.0% | 0.07% | -9.6% |
Q2 2021 | $3,136,000 | -17.4% | 320,698 | 0.0% | 0.07% | -14.1% |
Q1 2021 | $3,797,000 | +34.8% | 320,698 | -10.7% | 0.08% | +30.8% |
Q4 2020 | $2,816,000 | +71.5% | 359,133 | +48.7% | 0.06% | +58.5% |
Q3 2020 | $1,642,000 | -9.4% | 241,463 | 0.0% | 0.04% | 0.0% |
Q2 2020 | $1,813,000 | +10.6% | 241,463 | -7.5% | 0.04% | 0.0% |
Q1 2020 | $1,639,000 | -48.0% | 260,938 | +25.4% | 0.04% | -33.9% |
Q4 2019 | $3,154,000 | +17.1% | 208,038 | -20.7% | 0.06% | +3.3% |
Q3 2019 | $2,693,000 | -19.4% | 262,454 | +15.8% | 0.06% | -24.1% |
Q2 2019 | $3,342,000 | -3.5% | 226,558 | +7.7% | 0.08% | -3.7% |
Q1 2019 | $3,464,000 | +165.4% | 210,349 | -8.2% | 0.08% | +86.4% |
Q4 2018 | $1,305,000 | +47.5% | 229,019 | +210.7% | 0.04% | +76.0% |
Q3 2018 | $885,000 | +31.1% | 73,700 | +47.4% | 0.02% | +56.2% |
Q2 2018 | $675,000 | – | 50,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
GILDER GAGNON HOWE & CO LLC | 3,770,759 | $27,451,000 | 0.14% |